Skip to main content
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1994 Apr;86(4):270–272.

Intact splenic function in cystic fibrosis.

N J Barrios 1, M Kiernan 1, R Beckerman 1, S Davis 1
PMCID: PMC2607639  PMID: 8040902

Abstract

Patients with cystic fibrosis (CF) suffer from severe chronic pulmonary infections but rarely develop bacteremia/septicemia suggestive of an intact splenic mononuclear phagocyte function. The splenic function of 25 patients diagnosed with CF, aged 2 to 37 years, was evaluated using erythrocyte pit count by direct interference contrast microscopy. Results were compared with patients with sickle cell disease and normal individuals. All CF patients displayed normal splenic function by pit count. The mean percentage of pitted erythrocytes was 0.20 +/- 0.28 (range: 0.0% to 1.0%) versus 0.19 +/- 0.33 (range: 0.0% to 1.4%) in normal eusplenic controls. There were no episodes of bacteremia or septicemia despite recurrent acute exacerbations of chronic bacterial bronchitis and the use of central lines. We conclude that splenic function in CF is unabridged and may account for the rarity of bacteremia/septicemia in patients with CF despite the high prevalence of chronic bronchial infection in this population.

Full text

PDF
270

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Casper J. T., Koethe S., Rodey G. E., Thatcher L. G. A new method for studying splenic reticuloendothelial dysfunction in sickle cell disease patients and its clinical application: a brief report. Blood. 1976 Feb;47(2):183–188. [PubMed] [Google Scholar]
  2. Feery B. J., Phelan P. D., Gallichio H. A., Hampson A. W. Antibody responses to influenza virus vaccine in patients with cystic fibrosis. Aust Paediatr J. 1979 Sep;15(3):181–182. doi: 10.1111/j.1440-1754.1979.tb01221.x. [DOI] [PubMed] [Google Scholar]
  3. GIBSON L. E., COOKE R. E. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics. 1959 Mar;23(3):545–549. [PubMed] [Google Scholar]
  4. Mantzouranis E. C., Rosen F. S., Colten H. R. Reticuloendothelial clearance in cystic fibrosis and other inflammatory lung diseases. N Engl J Med. 1988 Aug 11;319(6):338–343. doi: 10.1056/NEJM198808113190604. [DOI] [PubMed] [Google Scholar]
  5. Matthews W. J., Jr, Williams M., Oliphint B., Geha R., Colten H. R. Hypogammaglobulinemia in patients with cystic fibrosis. N Engl J Med. 1980 Jan 31;302(5):245–249. doi: 10.1056/NEJM198001313020501. [DOI] [PubMed] [Google Scholar]
  6. Sorensen R. U., Stern R. C., Chase P., Polmar S. H. Defective cellular immunity to gram-negative bacteria in cystic fibrosis patients. Infect Immun. 1979 Feb;23(2):398–402. doi: 10.1128/iai.23.2.398-402.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Sorensen R. U., Stern R. C., Polmar S. H. Cellular immunity to bacteria: impairment of in vitro lymphocyte responses to Pseudomonas aeruginosa in cystic fibrosis patients. Infect Immun. 1977 Dec;18(3):735–740. doi: 10.1128/iai.18.3.735-740.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Sorensen R. U., Stern R. C., Polmar S. H. Lymphocyte responsiveness to Pseudomonas aeruginosa in cystic fibrosis: Relationship to status of pulmonary disease in sibling pairs. J Pediatr. 1978 Aug;93(2):201–205. doi: 10.1016/s0022-3476(78)80496-x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES